The Potential of Adipose Stem Cells in Regenerative Medicine

Stem Cell Reviews and Reports

Volumn 7, Issue 2, 2011, Pages 269-291

  Lindroos, Bettina ^a   Suuronen, Riitta ^a,b   Miettinen, Susanna ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adipose stem cells; Defined serum free culturing conditions; Flow cytometry; Good manufacturing practice; Stem cell therapy

Indexed keywords

DIFFERENTIATION ANTIGEN;

ADIPOSE TISSUE; ADULT STEM CELL; ANIMAL; CELL DIFFERENTIATION; CLINICAL TRIAL (TOPIC); CULTURE TECHNIQUE; CYTOLOGY; HUMAN; IMMUNOLOGY; IMMUNOPATHOLOGY; METABOLISM; METHODOLOGY; REGENERATIVE MEDICINE; REVIEW; TRANSPLANTATION;

ADIPOSE TISSUE; ADULT STEM CELLS; ANIMALS; ANTIGENS, DIFFERENTIATION; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNE SYSTEM DISEASES; REGENERATIVE MEDICINE;

EID: 79955038911     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9193-7     Document Type: Review

References (222)

1. Pittenger, M. F., Mackay, A. M., Beck, S. C., et al. (1999). Multilineage potential of adult human mesenchymal stem cells. Science, 284, 143-147.
2. Gimble, J., & Guilak, F. (2003). Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy, 5, 362-369.
3. Bongso, A., Fong, C. Y., Ng, S. C., et al. (1994). Isolation and culture of inner cell mass cells from human blastocysts. Human Reproduction, 9, 2110-2117.
4. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282, 1145-1147.
5. Yamanaka, S. (2008). Pluripotency and nuclear reprogramming. Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, 363, 2079-2087.
6. Amabile, G., & Meissner, A. (2009). Induced pluripotent stem cells: current progress and potential for regenerative medicine. Trends in Molecular Medicine, 15, 59-68.
7. Cyranoski, D. (2008). Stem cells: 5 things to know before jumping on the iPS bandwagon. Nature, 452, 406-408.
8. Friedenstein, A. J., Petrakova, K. V., Kurolesova, A. I., et al. (1968). Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation, 6, 230-247.
9. Jaiswal, R. K., Jaiswal, N., Bruder, S. P., et al. (2000). Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. The Journal of Biological Chemistry, 275, 9645-9652.
10. Johnstone, B., Hering, T. M., Caplan, A. I., et al. (1998). In vitro chondrogenesis of bone marrow-derived mesenchymal progenitor cells. Experimental Cell Research, 238, 265-272.
11. Zuk, P. A. (2008). Tissue engineering craniofacial defects with adult stem cells? Are we ready yet? Pediatric Research, 63, 478-486.
12. Zuk, P. A., Zhu, M., Mizuno, H., et al. (2001). Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Engineering, 7, 211-228.
13. Zuk, P. A., Zhu, M., Ashjian, P., et al. (2002). Human adipose tissue is a source of multipotent stem cells. Molecular Biology of the Cell, 13, 4279-4295.
14. Gimble, J. M., Katz, A. J., & Bunnell, B. A. (2007). Adipose-derived stem cells for regenerative medicine. Circulation Research, 100, 1249-1260.
15. Planat-Benard, V., Silvestre, J. S., Cousin, B., et al. (2004). Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation, 109, 656-663.
16. Safford, K. M., Hicok, K. C., Safford, S. D., et al. (2002). Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochemical and Biophysical Research Communications, 294, 371-379.
17. Seo, M. J., Suh, S. Y., Bae, Y. C., et al. (2005). Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo. Biochemical and Biophysical Research Communications, 328, 258-264.
18. Timper, K., Seboek, D., Eberhardt, M., et al. (2006). Human adipose tissue-derived mesenchymal stem cells differentiate into insulin, somatostatin, and glucagon expressing cells. Biochemical and Biophysical Research Communications, 341, 1135-1140.
19. Winter, A., Breit, S., Parsch, D., et al. (2003). Cartilage-like gene expression in differentiated human stem cell spheroids: a comparison of bone marrow-derived and adipose tissue-derived stromal cells. Arthritis and Rheumatism, 48, 418-429.
20. Gonzalez-Rey, E., Gonzalez, M. A., Varela, N., et al. (2010). Human adipose-derived mesenchymal stem cells reduce inflammatory and T cell responses and induce regulatory T cells in vitro in rheumatoid arthritis. Annals of the Rheumatic Diseases, 69, 241-248.
21. Gonzalez-Rey, E., Anderson, P., Gonzalez, M. A., et al. (2009). Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut, 58, 929-939.
22. Meza-Zepeda, L. A., Noer, A., Dahl, J. A., et al. (2008). High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. Journal of Cellular and Molecular Medicine, 12, 553-563.
23. Dahl, J. A., Duggal, S., Coulston, N., et al. (2008). Genetic and epigenetic instability of human bone marrow mesenchymal stem cells expanded in autologous serum or fetal bovine serum. The International Journal of Developmental Biology, 52, 1033-1042.
24. Fang, B., Song, Y., Liao, L., et al. (2007). Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplantation Proceedings, 39, 3358-3362.
25. Fang, B., Song, Y., Lin, Q., et al. (2007). Human adipose tissue-derived mesenchymal stromal cells as salvage therapy for treatment of severe refractory acute graft-vs.-host disease in two children. Pediatric Transplantation, 11, 814-817.
26. Fang, B., Song, Y., Zhao, R. C., et al. (2007). Using human adipose tissue-derived mesenchymal stem cells as salvage therapy for hepatic graft-versus-host disease resembling acute hepatitis. Transplantation Proceedings, 39, 1710-1713.
27. Fang, B., Song, Y. P., Liao, L. M., et al. (2006). Treatment of severe therapy-resistant acute graft-versus-host disease with human adipose tissue-derived mesenchymal stem cells. Bone Marrow Transplantation, 38, 389-390.
28. Garcia-Olmo, D., Garcia-Arranz, M., & Herreros, D. (2008). Expanded adipose-derived stem cells for the treatment of complex perianal fistula including Crohn's disease. Expert Opinion on Biological Therapy, 8, 1417-1423.
29. Riordan, N. H., Ichim, T. E., Min, W. P., et al. (2009). Non-expanded adipose stromal vascular fraction cell therapy for multiple sclerosis. Journal of Translational Medicine, 7, 29.
30. Yoshimura, K., Sato, K., Aoi, N., et al. (2008). Cell-assisted lipotransfer for cosmetic breast augmentation: supportive use of adipose-derived stem/stromal cells. Aesthetic Plastic Surgery, 32, 48-55. discussion 56-47.
31. Yoshimura, K., Sato, K., Aoi, N., et al. (2008). Cell-assisted lipotransfer for facial lipoatrophy: efficacy of clinical use of adipose-derived stem cells. Dermatologic Surgery, 34, 1178-1185.
32. Lendeckel, S., Jodicke, A., Christophis, P., et al. (2004). Autologous stem cells (adipose) and fibrin glue used to treat widespread traumatic calvarial defects: case report. Journal of Craniomaxillofacial Surgery, 32, 370-373.
33. Mesimäki, K., Lindroos, B., Törnwall, J., et al. (2009). Novel maxillary reconstruction with ectopic bone formation by GMP adipose stem cells. International Journal of Oral and Maxillofacial Surgery, 38, 201-209.
34. Becker, A. J., McCulloch, E. A., & Till, J. E. (1963). Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells. Nature, 197, 452-454.
35. Orkin, S. H. (2000). Diversification of haematopoietic stem cells to specific lineages. Nature Reviews. Genetics, 1, 57-64.
36. Lagasse, E., Connors, H., Al-Dhalimy, M., et al. (2000). Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Natural Medicines, 6, 1229-1234.
37. Piersma, A. H., Brockbank, K. G., Ploemacher, R. E., et al. (1985). Characterization of fibroblastic stromal cells from murine bone marrow. Experimental Hematology, 13, 237-243.
38. Owen, M. (1988). Marrow stromal stem cells. Journal of Cell Science Supplement, 10, 63-76.
39. Caplan, A. I. (1991). Mesenchymal stem cells. Journal of Orthopaedic Research, 9, 641-650.
40. Pereira, R. F., Halford, K. W., O'Hara, M. D., et al. (1995). Cultured adherent cells from marrow can serve as long-lasting precursor cells for bone, cartilage, and lung in irradiated mice. Proceedings of the National Academy of Sciences of the United States of America, 92, 4857-4861.
41. Pereira, R. F., O'Hara, M. D., Laptev, A. V., et al. (1998). Marrow stromal cells as a source of progenitor cells for nonhematopoietic tissues in transgenic mice with a phenotype of osteogenesis imperfecta. Proceedings of the National Academy of Sciences of the United States of America, 95, 1142-1147.
42. Horwitz, E. M., Gordon, P. L., Koo, W. K., et al. (2002). Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proceedings of the National Academy of Sciences of the United States of America, 99, 8932-8937.
43. Horwitz, E. M., Prockop, D. J., Fitzpatrick, L. A., et al. (1999). Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Natural Medicines, 5, 309-313.
44. Horwitz, E. M., Prockop, D. J., Gordon, P. L., et al. (2001). Clinical responses to bone marrow transplantation in children with severe osteogenesis imperfecta. Blood, 97, 1227-1231.
45. Keating, A., Berkahn, L., & Filshie, R. (1998). A Phase I study of the transplantation of genetically marked autologous bone marrow stromal cells. Human Gene Therapy, 9, 591-600.
46. Dominici, M., Le Blanc, K., Mueller, I., et al. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8, 315-317.
47. Horwitz, E. M., Le Blanc, K., Dominici, M., et al. (2005). Clarification of the nomenclature for MSC: the International Society for Cellular Therapy position statement. Cytotherapy, 7, 393-395.
48. Caplan, A. I., & Bruder, S. P. (2001). Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends in Molecular Medicine, 7, 259-264.
49. Brinchmann, J. E. (2008). Expanding autologous multipotent mesenchymal bone marrow stromal cells. Journal of the Neurological Sciences, 265, 127-130.
50. Lindroos, B., Mäenpää, K., Ylikomi, T., et al. (2008). Characterisation of human dental stem cells and buccal mucosa fibroblasts. Biochemical and Biophysical Research Communications, 368, 329-335.
51. Grace, W., Gerold, S., Friedrich, H., et al. (2000). Stem Cell Plasticity in Mammals and Transdetermination in Drosophila: common themes? Stem Cells, 18, 409-414.
52. Donald, G. P., & Darwin, J. P. (2007). Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair - current views. Stem Cells, 25, 2896-2902.
53. Kahn, A. J., & Simmons, D. J. (1977). Chondrocyte-to-osteocyte transformation in grafts of perichondrium-free epiphyseal cartilage. Clinical Orthopaedics and Related Research 299-304.
54. Bennett, J. H., Joyner, C. J., Triffitt, J. T., et al. (1991). Adipocytic cells cultured from marrow have osteogenic potential. Journal of Cell Science, 99, 131-139.
55. Rada, T., Reis, R. L., & Gomes, M. E. (2009). Adipose tissue-derived stem cells and their application in bone and cartilage tissue engineering. Tissue Engineering. Part B: Reviews, 15, 113-125.
56. Huang, J. I., Zuk, P. A., Jones, N. F., et al. (2004). Chondrogenic potential of multipotential cells from human adipose tissue. Plastic and Reconstructive Surgery, 113, 585-594.
57. Daher, S. R., Johnstone, B. H., Phinney, D. G., et al. (2008). Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells, 26, 2664-2665.
58. Fraser, J. K., Wulur, I., Alfonso, Z., et al. (2006). Fat tissue: an underappreciated source of stem cells for biotechnology. Trends in Biotechnology, 24, 150-154.
59. Strem, B. M., Hicok, K. C., Zhu, M., et al. (2005). Multipotential differentiation of adipose tissue-derived stem cells. The Keio Journal of Medicine, 54, 132-141.
60. Tremolada, C., Palmieri, G., & Ricordi, C. Adipocyte transplantation and stem cells: plastic surgery meets regenerative medicine. Cell Transplantation.
61. Lin, K., Matsubara, Y., Masuda, Y., et al. (2008). Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy, 10, 417-426.
62. Lin, K., Matsubara, Y., Masuda, Y., et al. (2008). Characterization of adipose tissue-derived cells isolated with the Celution system. Cytotherapy, 10, 417-426.
63. Yamamoto, T., Gotoh, M., Hattori, R., et al. Periurethral injection of autologous adipose-derived stem cells for the treatment of stress urinary incontinence in patients undergoing radical prostatectomy: report of two initial cases. International Journal of Urology Urol 17, 75-82.
64. Duckers, H. J., Pinkernell, K., Milstein, A. M., et al. (2006). The bedside celution system for isolation of adipose derived regenerative cells. EuroIntervention, 2, 395-398.
65. Tissue Genesis Cell Isolation System. Tissue Genesis Incorporated. February 10th, 2009. Available at: http://www. tissuegenesis. com/.
66. Cytori's Celution® 700 System to be Regulated as a Medical Device by U. S. FDA. 20 Jul 2009. Available at: http://www. medicalnewstoday. com/articles/158091. php.
67. Fraser, J. K., Wulur, I., Alfonso, Z., et al. (2007). Differences in stem and progenitor cell yield in different subcutaneous adipose tissue depots. Cytotherapy, 9, 459-467.
68. Oedayrajsingh-Varma, M. J., van Ham, S. M., Knippenberg, M., et al. (2006). Adipose tissue-derived mesenchymal stem cell yield and growth characteristics are affected by the tissue-harvesting procedure. Cytotherapy, 8, 166-177.
69. Jurgens, W. J., Oedayrajsingh-Varma, M. J., Helder, M. N., et al. (2008). Effect of tissue-harvesting site on yield of stem cells derived from adipose tissue: implications for cell-based therapies. Cell and Tissue Research, 332, 415-426.
70. von Heimburg, D., Hemmrich, K., Haydarlioglu, S., et al. (2004). Comparison of viable cell yield from excised versus aspirated adipose tissue. Cells, Tissues, Organs, 178, 87-92.
71. Rodbell, M. (1964). Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. The Journal of Biological Chemistry, 239, 375-380.
72. Katz, A. J., Llull, R., Hedrick, M. H., et al. (1999). Emerging approaches to the tissue engineering of fat. Clinics in Plastic Surgery, 26, 587-603. viii.
73. Katz, A. J., Tholpady, A., Tholpady, S. S., et al. (2005). Cell surface and transcriptional characterization of human adipose-derived adherent stromal (hADAS) cells. Stem Cells, 23, 412-423.
74. Katz, A. J., Hedrick, M. H., Llull, R., et al. (2001). A novel device for the simple and efficient refinement of liposuctioned tissue. Plastic and Reconstructive Surgery, 107, 595-597.
75. Gronthos, S., Franklin, D. M., Leddy, H. A., et al. (2001). Surface protein characterization of human adipose tissue-derived stromal cells. Journal of Cellular Physiology, 189, 54-63.
76. Boquest, A. C., Shahdadfar, A., Brinchmann, J. E., et al. (2006). Isolation of stromal stem cells from human adipose tissue. Methods in Molecular Biology, 325, 35-46.
77. Simmons, P. J., & Torok-Storb, B. (1991). Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood, 78, 55-62.
78. Quirici, N., Soligo, D., Bossolasco, P., et al. (2002). Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Experimental Hematology, 30, 783-791.
79. Gronthos, S., Fitter, S., Diamond, P., et al. (2007). A novel monoclonal antibody (STRO-3) identifies an isoform of tissue nonspecific alkaline phosphatase expressed by multipotent bone marrow stromal stem cells. Stem Cells and Development, 16, 953-963.
80. Battula, V. L., Treml, S., Bareiss, P. M., et al. (2009). Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1. Haematologica, 94, 173-184.
81. Tapp, H., Hanley, E. N., Jr., Patt, J. C., et al. (2009). Adipose-derived stem cells: characterization and current application in orthopaedic tissue repair. Experimental Biology and Medicine (Maywood), 234, 1-9.
82. Garcia-Castro, J., Trigueros, C., Madrenas, J., et al. (2008). Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. Journal of Cellular and Molecular Medicine, 12, 2552-2565.
83. De Ugarte, D. A., Alfonso, Z., Zuk, P. A., et al. (2003). Differential expression of stem cell mobilization-associated molecules on multi-lineage cells from adipose tissue and bone marrow. Immunology Letters, 89, 267-270.
84. McIntosh, K., Zvonic, S., Garrett, S., et al. (2006). The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells, 24, 1246-1253.
85. Mitchell, J. B., McIntosh, K., Zvonic, S., et al. (2006). Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells, 24, 376-385.
86. Simmons, P. J., Masinovsky, B., Longenecker, B. M., et al. (1992). Vascular cell adhesion molecule-1 expressed by bone marrow stromal cells mediates the binding of hematopoietic progenitor cells. Blood, 80, 388-395.
87. Sudhoff, T., & Sohngen, D. (2002). Circulating endothelial adhesion molecules (sE-selectin, sVCAM-1 and sICAM-1) during rHuG-CSF-stimulated stem cell mobilization. Journal of Hematotherapy & Stem Cell Research, 11, 147-151.
88. Otto, T. C., & Lane, M. D. (2005). Adipose development: from stem cell to adipocyte. Critical Reviews in Biochemistry and Molecular Biology, 40, 229-242.
89. Deslex, S., Negrel, R., Vannier, C., et al. (1987). Differentiation of human adipocyte precursors in a chemically defined serum-free medium. International Journal of Obesity, 11, 19-27.
90. Hauner, H., Entenmann, G., Wabitsch, M., et al. (1989). Promoting effect of glucocorticoids on the differentiation of human adipocyte precursor cells cultured in a chemically defined medium. Journal of Clinical Investigation, 84, 1663-1670.
91. Sen, A., Lea-Currie, Y. R., Sujkowska, D., et al. (2001). Adipogenic potential of human adipose derived stromal cells from multiple donors is heterogeneous. Journal of Cellular Biochemistry, 81, 312-319.
92. Christodoulides, C., Lagathu, C., Sethi, J. K., et al. (2009). Adipogenesis and WNT signalling. Trends in Endocrinology and Metabolism, 20, 16-24.
93. Moldes, M., Zuo, Y., Morrison, R. F., et al. (2003). Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis. The Biochemical Journal, 376, 607-613.
94. Won Park, K., Halperin, D. S., & Tontonoz, P. (2008). Before they were fat: adipocyte progenitors. Cell Metabolism, 8, 454-457.
95. Gregoire, F. M., Smas, C. M., & Sul, H. S. (1998). Understanding adipocyte differentiation. Physiological Reviews, 78, 783-809.
96. Gimble, J. M., Morgan, C., Kelly, K., et al. (1995). Bone morphogenetic proteins inhibit adipocyte differentiation by bone marrow stromal cells. Journal of Cellular Biochemistry, 58, 393-402.
97. Lindroos, B., Aho, K.-L., Kuokkanen, H., et al. (2010). Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Engineering Part A, 16, 2281-2294.
98. Lindroos, B., Boucher, S., Chase, L., et al. (2009). Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. Cytotherapy, 11, 958-972.
99. Rajala, K., Lindroos, B., Hussein, S. M., et al. A defined and xeno-free culture method enabling the establishment of clinical-grade human embryonic, induced pluripotent and adipose stem cells. PLoS One, 5, e10246.
100. Zhou, S., Eid, K., & Glowacki, J. (2004). Cooperation between TGF-beta and Wnt pathways during chondrocyte and adipocyte differentiation of human marrow stromal cells. Journal of Bone and Mineral Research, 19, 463-470.
101. Takada, I., Kouzmenko, A. P., & Kato, S. (2009). Molecular switching of osteoblastogenesis versus adipogenesis: implications for targeted therapies. Expert Opinion on Therapeutic Targets, 13, 593-603.
102. Aubin, J. E., Liu, F., Malaval, L., et al. (1995). Osteoblast and chondroblast differentiation. Bone, 17, 77S-83S.
103. Liu, T. M., Martina, M., Hutmacher, D. W., et al. (2007). Identification of common pathways mediating differentiation of bone marrow- and adipose tissue-derived human mesenchymal stem cells into three mesenchymal lineages. Stem Cells, 25, 750-760.
104. Aubin, J. E. (2001). Regulation of osteoblast formation and function. Reviews in Endocrine & Metabolic Disorders, 2, 81-94.
105. Madras, N., Gibbs, A. L., Zhou, Y., et al. (2002). Modeling stem cell development by retrospective analysis of gene expression profiles in single progenitor-derived colonies. Stem Cells, 20, 230-240.
106. Halvorsen, Y. D., Franklin, D., Bond, A. L., et al. (2001). Extracellular matrix mineralization and osteoblast gene expression by human adipose tissue-derived stromal cells. Tissue Engineering, 7, 729-741.
107. Halvorsen, Y. C., Wilkison, W. O., & Gimble, J. M. (2000). Adipose-derived stromal cells-their utility and potential in bone formation. International Journal of Obesity and Related Metabolic Disorders, 24(Suppl 4), S41-S44.
108. Aksu, A. E., Rubin, J. P., Dudas, J. R., et al. (2008). Role of gender and anatomical region on induction of osteogenic differentiation of human adipose-derived stem cells. Annals of Plastic Surgery, 60, 306-322.
109. Zhu, M., Kohan, E., Bradley, J., et al. (2009). The effect of age on osteogenic, adipogenic and proliferative potential of female adipose-derived stem cells. Journal of Tissue Engineering and Regenerative Medicine, 3, 290-301.
110. Denker, A. E., Nicoll, S. B., & Tuan, R. S. (1995). Formation of cartilage-like spheroids by micromass cultures of murine C3H10T1/2 cells upon treatment with transforming growth factor-beta 1. Differentiation, 59, 25-34.
111. Wei, Y., Sun, X., Wang, W., et al. (2007). Adipose-derived stem cells and chondrogenesis. Cytotherapy, 9, 712-716.
112. Awad, H. A., Wickham, M. Q., Leddy, H. A., et al. (2004). Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials, 25, 3211-3222.
113. Knippenberg, M., Helder, M. N., Zandieh Doulabi, B., et al. (2006). Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochemical and Biophysical Research Communications, 342, 902-908.
114. Diekman, B. O., Estes, B. T., & Guilak, F. (2010). The effects of BMP6 overexpression on adipose stem cell chondrogenesis: Interactions with dexamethasone and exogenous growth factors. Journal of Biomedical Materials Research Part A, 93A, 994-1003.
115. Estes, B. T., Wu, A. W., & Guilak, F. (2006). Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6. Arthritis and Rheumatism, 54, 1222-1232.
116. Erickson, G. R., Gimble, J. M., Franklin, D. M., et al. (2002). Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochemical and Biophysical Research Communications, 290, 763-769.
117. Koga, H., Engebretsen, L., Brinchmann, J. E., et al. (2009). Mesenchymal stem cell-based therapy for cartilage repair: a review. Knee Surgery, Sports Traumatology, Arthroscopy.
118. Huang, J. I., Kazmi, N., Durbhakula, M. M., et al. (2005). Chondrogenic potential of progenitor cells derived from human bone marrow and adipose tissue: a patient-matched comparison. Journal of Orthopaedic Research, 23, 1383-1389.
119. Im, G. I., Shin, Y. W., & Lee, K. B. (2005). Do adipose tissue-derived mesenchymal stem cells have the same osteogenic and chondrogenic potential as bone marrow-derived cells? Osteoarthritis and Cartilage, 13, 845-853.
120. Kim, H. J., & Im, G. I. (2009). Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. Journal of Orthopaedic Research, 27, 612-619.
121. van Dijk, A., Niessen, H. W., Zandieh Doulabi, B., et al. (2008). Differentiation of human adipose-derived stem cells towards cardiomyocytes is facilitated by laminin. Cell and Tissue Research, 334, 457-467.
122. Bai, X., Pinkernell, K., Song, Y. H., et al. (2007). Genetically selected stem cells from human adipose tissue express cardiac markers. Biochemical and Biophysical Research Communications, 353, 665-671.
123. Song, Y. H., Gehmert, S., Sadat, S., et al. (2007). VEGF is critical for spontaneous differentiation of stem cells into cardiomyocytes. Biochemical and Biophysical Research Communications, 354, 999-1003.
124. Valina, C., Pinkernell, K., Song, Y. H., et al. (2007). Intracoronary administration of autologous adipose tissue-derived stem cells improves left ventricular function, perfusion, and remodelling after acute myocardial infarction. European Heart Journal, 28, 2667-2677.
125. Mizuno, H., Zuk, P. A., Zhu, M., et al. (2002). Myogenic differentiation by human processed lipoaspirate cells. Plastic and Reconstructive Surgery, 109, 199-209. discussion 210-191.
126. Madonna, R., Geng, Y.-J., & De Caterina, R. (2009). Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair. Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 1723-1729.
127. Miranville, A., Heeschen, C., Sengenes, C., et al. (2004). Improvement of postnatal neovascularization by human adipose tissue-derived stem cells. Circulation, 110, 349-355.
128. De Francesco, F., Tirino, V., Desiderio, V., et al. (2009). Human CD34+/CD90+ ASCs are capable of growing as sphere clusters, producing high levels of VEGF and forming capillaries. PLoS ONE, 4, e6537.
129. Boquest, A. C., Noer, A., Sorensen, A. L., et al. (2007). CpG methylation profiles of endothelial cell-specific gene promoter regions in adipose tissue stem cells suggest limited differentiation potential toward the endothelial cell lineage. Stem Cells, 25, 852-861.
130. Rehman, J., Traktuev, D., Li, J., et al. (2004). Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells. Circulation, 109, 1292-1298.
131. Kim, S. C., Han, D. J., & Lee, J. Y. Adipose tissue derived stem cells for regeneration and differentiation into insulin-producing cells. Current Stem Cell Research and Therapy, 5, 190-194.
132. Lee, J., Han, D. J., & Kim, S. C. (2008). In vitro differentiation of human adipose tissue-derived stem cells into cells with pancreatic phenotype by regenerating pancreas extract. Biochemical and Biophysical Research Communications, 375, 547-551.
133. Kang, H. M., Kim, J., Park, S., et al. (2009). Insulin-secreting cells from human eyelid-derived stem cells alleviate type I diabetes in immunocompetent mice. Stem Cells, 27, 1999-2008.
134. Lin, G., Wang, G., Liu, G., et al. (2009). Treatment of type 1 diabetes with adipose tissue-derived stem cells expressing pancreatic duodenal homeobox 1. Stem Cells and Development, 18, 1399-1406.
135. Talens-Visconti, R., Bonora, A., Jover, R., et al. (2006). Hepatogenic differentiation of human mesenchymal stem cells from adipose tissue in comparison with bone marrow mesenchymal stem cells. World Journal of Gastroenterology, 12, 5834-5845.
136. Dhar, S., Yoon, E. S., Kachgal, S., et al. (2007). Long-term maintenance of neuronally differentiated human adipose tissue-derived stem cells. Tissue Engineering, 13, 2625-2632.
137. Ashjian, P. H., Elbarbary, A. S., Edmonds, B., et al. (2003). In vitro differentiation of human processed lipoaspirate cells into early neural progenitors. Plastic and Reconstructive Surgery, 111, 1922-1931.
138. Aluigi, M. G., Coradeghini, R., Guida, C., et al. (2009). Pre-adipocytes commitment to neurogenesis 1: preliminary localisation of cholinergic molecules. Cell Biology International, 33, 594-601.
139. Burger, S. R. (2000). Design and operation of a current good manufacturing practices cell-engineering laboratory. Cytotherapy, 2, 111-122.
140. Harvath, L. (2000). Food and Drug Administration's proposed approach to regulation of hematopoietic stem/progenitor cell products for therapeutic use. Transfusion Medicine Reviews, 14, 104-111.
141. DIRECTIVE 2001/83/EC of the European Parliament and of the Council on the Community Code Relating to Medicinal Products for Human Use. The European Parliament and of the Council of the Community. Available at: http://www. emea. europa. eu/pdfs/human/pmf/2001-83-EC. pdf.
142. Guideline on Human Cell-Based Medicinal Products. EMEA, Committee for Human Medicinal Products. Available at: http://www. emea. europa. eu/pdfs/human/cpwp/41086906enfin. pdf.
143. Rehmann, W., Morgan, G. The Regulation of Advanced Therapies: Perspectives from the EU [Regulatory Feature]. February 2009. Available at: http://www. taylorwessing. com/uploads/tx_siruplawyermanagement/The_Regulation_of_Advanced_Therapies. pdf.
144. Halme, D. G., & Kessler, D. A. (2006). FDA regulation of stem-cell-based therapies. The New England Journal of Medicine, 355, 1730-1735.
145. Regulation (EC) no 1394/2007 of the European Parliament and of the Council. Official Journal of the European Union. Available at: http://eur-lex. europa. eu/LexUriServ/LexUriServ. do?uri=OJ: L: 2007: 324: 0121: 0137: en: PDF.
146. Sensebé, L., Krampera, M., Schrezenmeier, H., et al. (2010). Mesenchymal stem cells for clinical application. Vox Sanguinis, 98, 93-107.
147. Kocaoemer, A., Kern, S., Kluter, H., et al. (2007). Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells, 25, 1270-1278.
148. Bieback, K., Hecker, A., Kocaomer, A., et al. (2009). Human alternatives to fetal bovine serum for the expansion of mesenchymal stromal cells from bone marrow. Stem Cells, 27, 2331-2341.
149. Herrera, B., & Inman, G. J. (2009). A rapid and sensitive bioassay for the simultaneous measurement of multiple bone morphogenetic proteins. Identification and quantification of BMP4, BMP6 and BMP9 in bovine and human serum. BMC Cell Biology, 10, 20.
150. Mirabet, V., Solves, P., Minana, M. D., et al. (2008). Human platelet lysate enhances the proliferative activity of cultured human fibroblast-like cells from different tissues. Cell and Tissue Banking, 9, 1-10.
151. Muramatsu, T., Pinontoan, R., & Okumura, J. (1995). Biopotency of fetal bovine serum, and insulin and insulin-like growth factors I and II in enhancing whole-body protein synthesis of chicken embryos cultured in vitro. Comparative Biochemistry and Physiology. Part C: Pharmacology, Toxicology & Endocrinology, 111, 281-286.
152. Gstraunthaler, G. (2003). Alternatives to the use of fetal bovine serum: serum-free cell culture. Altex, 20, 275-281.
153. Katz, A. J., & Parker, A. M. (2006). Methods and Compositions for Growing Adipose Stem Cells, WO 2007/030652 A2: 69.
154. Kim, S. J., Cho, H. H., Kim, Y. J., et al. (2005). Human adipose stromal cells expanded in human serum promote engraftment of human peripheral blood hematopoietic stem cells in NOD/SCID mice. Biochemical and Biophysical Research Communications, 329, 25-31.
155. Spees, J. L., Gregory, C. A., Singh, H., et al. (2004). Internalized antigens must be removed to prepare hypoimmunogenic mesenchymal stem cells for cell and gene therapy. Molecular Therapy, 9, 747-756.
156. Heiskanen, A., Satomaa, T., Tiitinen, S., et al. (2007). N-glycolylneuraminic acid xenoantigen contamination of human embryonic and mesenchymal stem cells is substantially reversible. Stem Cells, 25, 197-202.
157. Martin, M. J., Muotri, A., Gage, F., et al. (2005). Human embryonic stem cells express an immunogenic nonhuman sialic acid. Natural Medicines, 11, 228-232.
158. Mackensen, A., Drager, R., Schlesier, M., et al. (2000). Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunology, Immunotherapy, 49, 152-156.
159. Selvaggi, T. A., Walker, R. E., & Fleisher, T. A. (1997). Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. Blood, 89, 776-779.
160. Will, R. G., Ironside, J. W., Zeidler, M., et al. (1996). A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921-925.
161. Stute, N., Holtz, K., Bubenheim, M., et al. (2004). Autologous serum for isolation and expansion of human mesenchymal stem cells for clinical use. Experimental Hematology, 32, 1212-1225.
162. Shahdadfar, A., Fronsdal, K., Haug, T., et al. (2005). In vitro expansion of human mesenchymal stem cells: choice of serum is a determinant of cell proliferation, differentiation, gene expression, and transcriptome stability. Stem Cells, 23, 1357-1366.
163. Shigeno, Y., & Ashton, B. A. (1995). Human bone-cell proliferation in vitro decreases with human donor age. The Journal of Bone and Joint Surgery British Volume, 77, 139-142.
164. Koller, M. R., Maher, R. J., Manchel, I., et al. (1998). Alternatives to animal sera for human bone marrow cell expansion: human serum and serum-free media. Journal of Hematotherapy, 7, 413-423.
165. Nimura, A., Muneta, T., Koga, H., et al. (2008). Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum. Arthritis and Rheumatism, 58, 501-510.
166. Anselme, K., Broux, O., Noel, B., et al. (2002). In vitro control of human bone marrow stromal cells for bone tissue engineering. Tissue Engineering, 8, 941-953.
167. Yamamoto, N., Isobe, M., Negishi, A., et al. (2003). Effects of autologous serum on osteoblastic differentiation in human bone marrow cells. Journal of Medical and Dental Sciences, 50, 63-69.
168. Oreffo, R. O., & Triffitt, J. T. (1999). Future potentials for using osteogenic stem cells and biomaterials in orthopedics. Bone, 25, 5S-9S.
169. Su, C. Y., Kuo, Y. P., Lin, Y. C., et al. (2009). A virally inactivated functional growth factor preparation from human platelet concentrates. Vox Sanguinis, 97, 119-128.
170. Luttun, A., Ross, J. J., Verfaillie, C., et al. (2006). Differentiation of multipotent adult progenitor cells into functional endothelial and smooth muscle cells. Curr Protoc Immunol; Chapter 22: Unit 22F 29.
171. Caterson, E. J., Nesti, L. J., Danielson, K. G., et al. (2002). Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation. Molecular Biotechnology, 20, 245-256.
172. Parker, A. M., Shang, H., Khurgel, M., et al. (2007). Low serum and serum-free culture of multipotential human adipose stem cells. Cytotherapy, 9, 637-646.
173. Frechette, J. P., Martineau, I., & Gagnon, G. (2005). Platelet-rich plasmas: growth factor content and roles in wound healing. Journal of Dental Research, 84, 434-439.
174. Johansson, L., Klinth, J., Holmqvist, O., et al. (2003). Platelet lysate: a replacement for fetal bovine serum in animal cell culture? Cytotechnology, 42, 67-74.
175. Salvadé, A., Mina, P. D., Gaddi, D., et al. (2010). Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Engineering. Part C: Methods, 16, 201-214.
176. Qizhou, L., Elias, L., Keng Suan, Y., et al. (2007). Derivation of clinically compliant MSCs from CD105+, CD24- differentiated human ESCs. Stem Cells, 25, 425-436.
177. Meuleman, N., Tondreau, T., Delforge, A., et al. (2006). Human marrow mesenchymal stem cell culture: serum-free medium allows better expansion than classical alpha-MEM medium. European Journal of Haematology, 76, 309-316.
178. Izadpanah, R., Kaushal, D., Kriedt, C., et al. (2008). Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Research, 68, 4229-4238.
179. Boquest, A. C., Shahdadfar, A., Fronsdal, K., et al. (2005). Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Molecular Biology of the Cell, 16, 1131-1141.
180. Guilak, F. (2002). Functional tissue engineering: the role of biomechanics in reparative medicine. Annals of the New York Academy of Sciences, 961, 193-195.
181. Sundelacruz, S., & Kaplan, D. L. (2009). Stem cell- and scaffold-based tissue engineering approaches to osteochondral regenerative medicine. Seminars in Cell & Developmental Biology, 20, 646-655.
182. Le Blanc, K., Tammik, L., Sundberg, B., et al. (2003). Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scandinavian Journal of Immunology, 57, 11-20.
183. Bartholomew, A., Sturgeon, C., Siatskas, M., et al. (2002). Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Experimental Hematology, 30, 42-48.
184. Tse, W. T., Pendleton, J. D., Beyer, W. M., et al. (2003). Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation, 75, 389-397.
185. Lazarus, H., Curtin, P., Devine, S., et al. (2000). Role of mesenchymal stem cells (MSC) in allogeneic transplantation: Early phase I clinical results. Blood, 96, 1691.
186. Jorgensen, C., Djouad, F., Apparailly, F., et al. (2003). Engineering mesenchymal stem cells for immunotherapy. Gene Therapy, 10, 928-931.
187. Aust, L., Devlin, B., Foster, S. J., et al. (2004). Yield of human adipose-derived adult stem cells from liposuction aspirates. Cytotherapy, 6, 7-14.
188. Cui, L., Yin, S., Liu, W., et al. (2007). Expanded adipose-derived stem cells suppress mixed lymphocyte reaction by secretion of prostaglandin E2. Tissue Engineering, 13, 1185-1195.
189. Puissant, B., Barreau, C., Bourin, P., et al. (2005). Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. British Journal Haematology, 129, 118-129.
190. Niemeyer, P., Vohrer, J., Schmal, H., et al. (2008). Survival of human mesenchymal stromal cells from bone marrow and adipose tissue after xenogenic transplantation in immunocompetent mice. Cytotherapy, 10, 784-795.
191. Yanez, R., Lamana, M. L., Garcia-Castro, J., et al. (2006). Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells, 24, 2582-2591.
192. Kucerova, L., Altanerova, V., Matuskova, M., et al. (2007). Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Research, 67, 6304-6313.
193. Yu, J. M., Jun, E. S., Bae, Y. C., et al. (2008). Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells and Development, 17, 463-473.
194. Muehlberg, F. L., Song, Y. H., Krohn, A., et al. (2009). Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis, 30, 589-597.
195. Cousin, B., Ravet, E., Poglio, S., et al. (2009). Adult stromal cells derived from human adipose tissue provoke pancreatic cancer cell death both in vitro and in vivo. PLoS ONE, 4, e6278.
196. Grisendi, G., Bussolari, R., Cafarelli, L., et al. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy. Cancer Research, 70, 3718-3729.
197. Garcia-Olmo, D., Garcia-Arranz, M., Garcia, L. G., et al. (2003). Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn's disease: a new cell-based therapy. International Journal of Colorectal Disease, 18, 451-454.
198. Garcia-Olmo, D., Garcia-Arranz, M., Herreros, D., et al. (2005). A phase I clinical trial of the treatment of Crohn's fistula by adipose mesenchymal stem cell transplantation. Diseases of the Colon and Rectum, 48, 1416-1423.
199. Garcia-Olmo, D., Herreros, D., Pascual, I., et al. (2009). Expanded adipose-derived stem cells for the treatment of complex perianal fistula: a phase II clinical trial. Diseases of the Colon and Rectum, 52, 79-86.
200. Garcia-Olmo, D., Herreros, D., Pascual, M., et al. (2009). Treatment of enterocutaneous fistula in Crohn's Disease with adipose-derived stem cells: a comparison of protocols with and without cell expansion. International Journal of Colorectal Disease, 24, 27-30.
201. Trivedi, H. L., Vanikar, A. V., Thakker, U., et al. (2008). Human adipose tissue-derived mesenchymal stem cells combined with hematopoietic stem cell transplantation synthesize insulin. Transplantation Proceedings, 40, 1135-1139.
202. Alvarez, P. D., Garcia-Arranz, M., Georgiev-Hristov, T., et al. (2008). A new bronchoscopic treatment of tracheomediastinal fistula using autologous adipose-derived stem cells. Thorax, 63, 374-376.
203. Stillaert, F. B., Di Bartolo, C., Hunt, J. A., et al. (2008). Human clinical experience with adipose precursor cells seeded on hyaluronic acid-based spongy scaffolds. Biomaterials, 29, 3953-3959.
204. Rogers, S. N., Lakshmiah, S. R., Narayan, B., et al. (2003). A comparison of the long-term morbidity following deep circumflex iliac and fibula free flaps for reconstruction following head and neck cancer. Plastic and Reconstructive Surgery, 112, 1517-1525. discussion 1526-1517.
205. Conejero, J. A., Lee, J. A., Parrett, B. M., et al. (2006). Repair of palatal bone defects using osteogenically differentiated fat-derived stem cells. Plastic and Reconstructive Surgery, 117, 857-863.
206. Kilroy, G. E., Foster, S. J., Wu, X., et al. (2007). Cytokine profile of human adipose-derived stem cells: expression of angiogenic, hematopoietic, and pro-inflammatory factors. Journal of Cellular Physiology, 212, 702-709.
207. Follmar, K. E., Decroos, F. C., Prichard, H. L., et al. (2006). Effects of glutamine, glucose, and oxygen concentration on the metabolism and proliferation of rabbit adipose-derived stem cells. Tissue Engineering, 12, 3525-3533.
208. Moon, M. H., Kim, S. Y., Kim, Y. J., et al. (2006). Human adipose tissue-derived mesenchymal stem cells improve postnatal neovascularization in a mouse model of hindlimb ischemia. Cellular Physiology and Biochemistry, 17, 279-290.
209. Di Nicola, M., Carlo-Stella, C., Magni, M., et al. (2002). Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 99, 3838-3843.
210. Aggarwal, S., & Pittenger, M. F. (2005). Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood, 105, 1815-1822.
211. Rasmusson, I., Ringden, O., Sundberg, B., et al. (2005). Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Experimental Cell Research, 305, 33-41.
212. Glennie, S., Soeiro, I., Dyson, P. J., et al. (2005). Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105, 2821-2827.
213. Beyth, S., Borovsky, Z., Mevorach, D., et al. (2005). Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood, 105, 2214-2219.
214. Rasmusson, I., Ringden, O., Sundberg, B., et al. (2003). Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 76, 1208-1213.
215. Grimes, B. R., Steiner, C. M., Merfeld-Clauss, S., et al. (2009). Interphase FISH demonstrates that human adipose stromal cells maintain a high level of genomic stability in long-term culture. Stem Cells and Development, 18, 717-724.
216. Rubio, D., Garcia-Castro, J., Martin, M. C., et al. (2005). Spontaneous human adult stem cell transformation. Cancer Research, 65, 3035-3039.
217. Wellen, K. E., & Hotamisligil, G. S. (2003). Obesity-induced inflammatory changes in adipose tissue. Journal of Clinical Investigation, 112, 1785-1788.
218. Lindroos, B. (2009). Characterization and optimization of in vitro culture conditions of adult stem cells for clinical cell therapy [PhD Thesis]. Tampere: Faculty of Medicine University of Tampere.
219. Lindroos, B., Aho, K.-L., Kuokkanen, H., et al. Differential gene expression in adipose stem cells cultured in allogeneic human serum versus fetal bovine serum. Tissue Engineering Part A.0.
220. Kern, S., Eichler, H., Stoeve, J., et al. (2006). Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24, 1294-1301.
221. Rebelatto, C. K., Aguiar, A. M., Moretao, M. P., et al. (2008). Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue. Experimental Biology and Medicine, 233, 901-913.
222. Zannettino, A. C., Paton, S., Arthur, A., et al. (2008). Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo. Journal of Cellular Physiology, 214, 413-421.